Patent · US Expired

Contrast medium for magnetic resonance imaging using physiologically tolerable manganese compound

US5716598A · kind A · utility

6Cited by
10References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 5, 1995
Grant dateFeb 10, 1998
Priority date
Expiry dateJun 5, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K49/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided a contrast medium composition for magnetic resonance imaging comprising a physiologically tolerable manganese compound, a physiologically tolerable reducing compound containing an .alpha.-hydroxy ketone group, or salt thereof and a physiologically tolerable carrier or excipient, having a manganese concentration of at least 0.3 mM or being in a dosage unit form containing at least 300 .mu.mol manganese. Such compositions are particularly suitable for imaging of the liver.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.